Cystadenocarcinoma, Mucinous - 25 Studies Found Status Study Active, not recruiting Study Name: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Clear Cell Cystadenocarcinoma Biological: denileukin diftitox Completed Study Name: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys Date: 2003-05-06 Interventions: Drug: paclitaxel Given IV Completed Study Name: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condition: Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovaria Date: 1999-11-01 Interventions: Drug: paclitaxel Given IV Recruiting Study Name: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors Condition: Adult Glioblastoma Endometrial Clear Cell Adenocarcinoma E Date: 2014-05-16 Interventions: Biological: Bevacizumab Given Completed Study Name: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys Date: 2009-10-09 Interventions: Drug: belinostat Given IV Completed Study Name: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Completed Study Name: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys Date: 2007-04-25 Interventions: Biological: sargramostim Given Completed Study Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys Date: 2004-03-08 Interventions: Procedure: adjuvant therapy Drug: paclitax Completed Study Name: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Condition: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Drug: Carboplatin Given IV Recruiting Study Name: Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Tumor Other: Laboratory Biomarker Analysis <<< Previous | Next >>>